Dedicated nursing care pathway improved management of opioid-poisoned patients in the emergency department: A before-after observational study.


Journal

Emergency medicine Australasia : EMA
ISSN: 1742-6723
Titre abrégé: Emerg Med Australas
Pays: Australia
ID NLM: 101199824

Informations de publication

Date de publication:
02 2023
Historique:
revised: 26 07 2022
received: 10 03 2022
accepted: 26 07 2022
pubmed: 16 8 2022
medline: 19 1 2023
entrez: 15 8 2022
Statut: ppublish

Résumé

Opioid overdose is increasing and accounts for two-thirds of poisoning deaths. Opioid induced respiratory depression is life-threatening and can be under-recognised even in the hospital setting. We aimed to evaluate the effect of a care pathway on the management of opioid-poisoned patients. This is a before-after observational study following the introduction of a nursing care pathway for opioid-poisoned patients presenting to ED. Medical records were retrospectively reviewed pre (6-month period 1 year prior) and post (9-month period following) the introduction of the pathway. The primary outcome was the proportion of documented episodes of respiratory depression (respiratory rate <10 or oxygen saturation <93% on room air) receiving naloxone. Secondary outcomes were time to naloxone, number of documented observations (first 4 h) and length of stay. There were 111 patients included in the study, 61 pre-intervention and 50 post-intervention (35 followed the pathway). A significantly larger proportion of patients received naloxone for respiratory depression when the pathway was used (134/200 [67%] vs 34/118 [29%], difference 38%, 95% CI 28-48%). The median time to naloxone was similar (pathway 28.5 min vs no pathway 35 min, difference -6.5 min, 95% CI -19 to 12 min). Documentation increased when the pathway was used (12.0 observations/presentation vs 7.5 observations/presentation, difference 4.5 observations/patient, 95% CI 2.1-7.0 observations/patient). Length of stay was similar (pathway 16.7 h vs no pathway 15.3 h, difference 1.4 h, 95% CI -2.4 to 5.9 h). Following the introduction of a dedicated opioid poisoning nursing care pathway, naloxone delivery and observation documentation increased. A care pathway may improve ED management of opioid poisoning.

Identifiants

pubmed: 35970763
doi: 10.1111/1742-6723.14056
pmc: PMC10087689
doi:

Substances chimiques

Analgesics, Opioid 0
Narcotic Antagonists 0
Poisons 0
Naloxone 36B82AMQ7N

Types de publication

Observational Study Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

69-73

Subventions

Organisme : Princess Alexandra Hospital Foundation
ID : Emergency Medicine Small Grant

Informations de copyright

© 2022 The Authors. Emergency Medicine Australasia published by John Wiley & Sons Australia, Ltd on behalf of Australasian College for Emergency Medicine.

Références

BMC Anesthesiol. 2021 Mar 20;21(1):88
pubmed: 33743588
Nurs Case Manag. 1997 Sep-Oct;2(5):229-37
pubmed: 9392266
Nurs Stand. 1999 Aug 11-17;13(47):36-7
pubmed: 10661188
Pharmacy (Basel). 2021 May 07;9(2):
pubmed: 34067224
Postgrad Med J. 2011 May;87(1027):379-81
pubmed: 21515873
Clin Toxicol (Phila). 2017 Nov;55(9):981-985
pubmed: 28617194
Collegian. 2005 Oct;12(4):22-8
pubmed: 16619925
Emerg Med J. 2012 Jun;29(6):482-6
pubmed: 21561983
Med J Malaysia. 1998 Mar;53(1):87-96
pubmed: 10968144
Clin Pharmacokinet. 1976;1(3):219-30
pubmed: 13957
Cochrane Database Syst Rev. 2010 Mar 17;(3):CD006632
pubmed: 20238347
Ther Adv Drug Saf. 2018 Jan;9(1):63-88
pubmed: 29318006

Auteurs

Katherine Isoardi (K)

Clinical Toxicology Unit and Emergency Department, Princess Alexandra Hospital, Brisbane, Queensland, Australia.
Clinical Toxicology Research Group, The University of Newcastle, Newcastle, New South Wales, Australia.
Faculty of Medicine, The University of Queensland, Brisbane, Queensland, Australia.

Benjamin Learmont (B)

Clinical Toxicology Unit and Emergency Department, Princess Alexandra Hospital, Brisbane, Queensland, Australia.

Benjamin Horan (B)

Clinical Toxicology Unit and Emergency Department, Princess Alexandra Hospital, Brisbane, Queensland, Australia.

Geoffrey Isbister (G)

Clinical Toxicology Research Group, The University of Newcastle, Newcastle, New South Wales, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH